|
Nova22007 is an investigational drug developed by Novagali for the treatment of dry eye and vernal keratoconjunctivitis (VKC). It is a Cyclosporine A ophthalmic product intended to be used to treat patients suffering from moderate-to-severe Dry Eye Syndrome.
|
